232599-02-9

Basic information

• Product Name: 1-benzhydryl-3-(4-chlorobenzyloxy)azetidine
• Synonyms: 1-benzhydryl-3-(4-chlorobenzyloxy)azetidine
• CAS NO: 232599-02-9
• Molecular Weight: 363.887
• Mol File: 232599-02-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-benzhydryl-3-(4-chlorobenzyloxy)azetidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzhydryl-3-(4-chlorobenzyloxy)azetidine(232599-02-9)
• EPA Substance Registry System: 1-benzhydryl-3-(4-chlorobenzyloxy)azetidine(232599-02-9)

Safety Data

• Hazardous Substances Data: 232599-02-9(Hazardous Substances Data)

Upstream product

• 18621-17-5 1-(diphenylmethyl)-3-hydroxyazetidine 
• 104-83-6 1-Chloro-4-(chloromethyl)benzene 
• 622-95-7 4-chlorobenzyl bromide 

Downstream Products

• 232599-11-0 3-(4-Fluorobenzyloxy)-1-(diphenylmethyl)azetidine 
• 232599-04-1 3-(3,4-Dichlorobenzyloxy)-1-(diphenylmethyl)azetidine 
• 897086-96-3 3-(4-chlorobenzyloxy)azetidine 
• 232599-08-5 3-(4-(Trifluoromethyl)benzyloxy)-1-(diphenylmethyl)azetidine 
• 232599-06-3 3-(3-(Trifluoromethyl)benzyloxy)-1-(diphenylmethyl)azetidine 

Relevant articles and documents

UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF

Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL.

Azetidinecarboxamide derivatives for treating CNS disorders

A compound of formula (1), wherein: R1is aryl; R2is H, alkyl or aryl; and R3is hydrogen or alkyl; pharmaceutically acceptable addition compounds thereof; and the use of the compounds in therapy, particularly for the treatment and prophylaxis of CNS disorders such as anxiety and epilepsy.